Patent ID: 8512727

Claim:
An intravenous injection pharmaceutical dosage form comprising: (a) a liquid dispersion medium selected from the group consisting of water, an aqueous salt solution, safflower oil, ethanol, t-butanol, hexane and glycol; (b) particles of meloxicam or a salt thereof having an effective average particle size of less than 200 nm; and (c) polyvinylpyrrolidone and sodium deoxycholate as surface stabilizers adsorbed on the surface of the meloxicam particles, wherein: (i) the surface stabilizer are essentially free of intermolecular cross-linkages; (ii) meloxicam is present in an amount of from about 99.5% to about 0.001%, by weight, based on the total combined weight of the meloxicam and the surface stabilizers; and (iii) the surface stabilizers are present in an amount of from about 0.01% to about 99.5%, by weight, based on the total combined weight of the meloxicam and the surface stabilizers.